Nuvation bio inc.NUVB-WT.US Overview
US StockHealthcare
(No presentation for NUVB-WT)
NUVB-WT Overall Performance
NUVB-WT AI Analysis & Strategy
NUVB-WT Recent Performance
2.61%
Nuvation bio inc.
0.81%
Avg of Sector
-1.14%
S&P500
NUVB-WT PowerScanner
NUVB-WT Key Information
NUVB-WT Valuation Metrics
NUVB-WT Earnings Table
NUVB-WT Profile
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.